In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...

This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...

Terumo Blood and Cell Technologies has entered into a memorandum of understanding (MOU) with South Korea’s KBIOHealth to jointly develop workforce training initiatives aimed at enhancing cell ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.

Researchers from City of Hope develop test using machine learning to predict immunotherapy response in lymphoma patients: Los Angeles Wednesday, April 2, 2025, 12:00 Hrs [IST] Res ...

On Tuesday, a Broadalbin man with blood cancer was the first patient to receive a groundbreaking cancer treatment at a local ...

Age-related neurodegenerative disorders — motor neuron diseases, demyelinating diseases, Alzheimer’s disease, and other proteinopathies — are at an ‘inflection point.’ ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

A nationwide team led by researchers at Baylor College of Medicine, Texas Children's Hospital and UPMC Children's Hospital of ...

Around 5,000 blood cancer patients could benefit from 13 treatments recommended by NICE in 2024. This is the largest number of positive recommendations in a single year for blood cancer treatments.